3.90
Lixte Biotechnology Holdings Inc Borsa (LIXT) Ultime notizie
What drives Lixte Biotechnology Holdings Inc. stock priceFree Technical Analysis Support - jammulinksnews.com
What analysts say about Lixte Biotechnology Holdings Inc. stockSky-high profits - Autocar Professional
What drives Lixte Biotechnology Holdings Inc. Equity Warrant stock priceRapid profit acceleration - Autocar Professional
LIXT adds 2 directors after Series B deal; CMO resigns, board reshuffle | LIXTW SEC FilingForm 8-K - Stock Titan
Lixte Biotechnology Holdings Inc. Stock Analysis and ForecastStrongest growth potential - Autocar Professional
Lixte Biotechnology Holdings Inc. Equity Warrant Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com
Is Lixte Biotechnology Holdings Inc. a good long term investmentAccelerated investment success - jammulinksnews.com
Published on: 2025-07-19 22:24:49 - jammulinksnews.com
LIXTE Biotechnology regains Nasdaq compliance - MSN
What analysts say about Lixte Biotechnology Holdings Inc. Equity Warrant stockSuperior capital gains - jammulinksnews.com
Lixte Biotechnology shares fall 2.38% premarket after regaining Nasdaq compliance. - AInvest
Fluence Energy's Price Target Raised by Barclays: A Shift in Market Dynamics? - AInvest
LIXTE Biotechnology Regains Nasdaq Listing Compliance with $5 Million Financing - AInvest
What analysts say about Lixte Biotechnology Holdings Inc. stock outlookRapid Gain Targets - Newser
Lixte Biotechnology Regains Nasdaq Compliance After Fundraising - The Globe and Mail
Lixte Biotechnology shares fall 3.23% premarket after closing a $5 million private placement. - AInvest
LIXTE Biotechnology Regains Nasdaq Compliance with $5M Financing - AInvest
What makes Lixte Biotechnology Holdings Inc. Equity Warrant stock price move sharplyFree Consultation - beatles.ru
LIXTE Biotechnology Meets Nasdaq Listing Requirement, Shares Down - AInvest
LIXTE Biotechnology's Compliance Win: A Turning Point for Clinical Gains and Stock Stability? - AInvest
LIXTE Biotechnology Holdings, Inc. Regains Nasdaq Compliance Following Successful Capital Raise - Nasdaq
LIXTE Biotechnology regains Nasdaq compliance after $5M funding. - AInvest
LIXTE Biotechnology Holdings Regains Compliance with Nasdaq’s Continued Listing Requirements - GlobeNewswire
LIXTE Biotechnology Holdings Regains Nasdaq Listing Compliance with New Financing - AInvest
LIXTE Secures $6.5M Funding, Maintains Nasdaq Listing While Advancing Cancer Drug Trials - Stock Titan
How Lixte Biotechnology Holdings Inc. Equity Warrant stock performs during market volatility - Newser
What makes Lixte Biotechnology Holdings Inc. stock price move sharplyFree Stock Selection - Newser
How Lixte Biotechnology Holdings Inc. stock performs during market volatilityBreakout Level Watch - Newser
Why Lixte Biotechnology Holdings Inc. Equity Warrant stock attracts strong analyst attentionFree Access to Community - Newser
Why Lixte Biotechnology Holdings Inc. stock attracts strong analyst attentionTop Performer Shortlist - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):